Market Overview:
The global ursodeoxycholic acid market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of liver diseases, rising awareness about the benefits of ursodeoxycholic acid, and growing demand for natural and herbal products. Based on type, the global ursodeoxycholic acid market is segmented into synthetic UDCA and extraction UDCA. Synthetic UDCA dominates the market owing to its high efficacy and low price as compared to extraction UDCA. However, with increasing consumer preference for organic products, extraction UDCA is expected to witness higher growth during the forecast period. Based on application, the global ursodeoxycholic acid market is segmented into pharmacy and health products. Pharmacy dominates the market due to increased use of ursodeoxycholic acid in treating various liver diseases such as primary biliary cirrhosis (PBC), cholestasis of pregnancy (COP), chronic hepatitis C (CHC) etc.
Product Definition:
Ursodeoxycholic acid (UDCA) is a bile acid found in the liver of many animals. It is used as a medication to dissolve gallstones and to treat primary biliary cirrhosis. UDCA appears to work by decreasing the production of cholesterol in the liver and by increasing its breakdown and removal from the body.
Synthetic UDCA:
Uracil UDCA, also known as 4-Cholauric Acid or SyntheticUDCA, is a non-natural urea derivative. It was first synthesized in the laboratory in the early 1960s by Japanese researchers. Since that time it has been extensively studied and used for its chiral binding properties and found to be more efficient than natural UDCA (3-dehydrocarnatine)in terms of potency & selectivity towards cancer cells.
Extraction UDCA:
Extraction UDCA is a new and novel method for the isolation of uursodeoxycholic acid (UDA) which has shown higher yields in comparison to other conventional methods. The product is being studied as a potential cholinesterase inhibitor for the treatment of Alzheimer’s disease, Parkinson’s disease, and brain cancer. It can also be used in combination with other drugs for treating diseases such as cardiovascular disorders and gastrointestinal conditions.
Application Insights:
Pharmacy was the dominant application segment and accounted for a revenue share of around 60.0% in 2017. The product is used as an alternative to bile acids in the manufacture of pharmaceuticals, owing to its cholic acid content. It is also employed as a cholagogue, which helps stimulate the production of more bile acids after eating fatty foods, thereby aiding in weight loss programs. Furthermore, it plays an important role during pregnancy by helping with childbirth and preventing post-partum hemorrhage and death among infants due to improper liver function.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. This can be attributed to increasing consumer awareness regarding cosmetic products, rising disposable income of middle-class population, and high demand for pharmaceutical grade cosmetics from developing countries such as China and India. The region is also anticipated to witness a significant rise in demand for skincare products owing to growing concerns over skin problems among consumers.
Europe accounted for more than 25% of the total revenue share in 2017 on account of high product consumption coupled with presence of major manufacturers including Avantor Performance Materials Inc., Nippon Paint Holdings Co., Ltd., PPG Industries, Sherwin-Williams Company are some factors that can be attributed to this growth rate.
Growth Factors:
- Increasing prevalence of liver diseases and disorders
- Rising awareness about the benefits of ursodeoxycholic acid therapy
- Growing demand for ursodeoxycholic acid in the pharmaceuticals industry
- Technological advancements in the field of drug delivery systems
- Expansion of distribution channels
Scope Of The Report
Report Attributes
Report Details
Report Title
Ursodeoxycholic Acid Market Research Report
By Type
Synthetic UDCA, Extraction UDCA
By Application
Pharmacy, Health Products
By Companies
ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhangshanbelling, Dipharma Francis, Grindeks, Erregierre, Abil Chempharma, Biotavia Labs, Suzhou Tianlu, Arcelor Chemicals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Ursodeoxycholic Acid Market Report Segments:
The global Ursodeoxycholic Acid market is segmented on the basis of:
Types
Synthetic UDCA, Extraction UDCA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmacy, Health Products
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ICE
- Mitsubishi Tanabe Pharma
- Daewoong Chemical
- PharmaZell GmbH
- Zhangshanbelling
- Dipharma Francis
- Grindeks
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Highlights of The Ursodeoxycholic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Synthetic UDCA
- Extraction UDCA
- By Application:
- Pharmacy
- Health Products
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ursodeoxycholic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ursodeoxycholic acid is a molecule found in the bile of mammals. It is produced by the liver and helps to break down fats. Ursodeoxycholic acid has been shown to have anti-inflammatory properties, which may help reduce the risk of chronic diseases such as heart disease, stroke, and cancer.
Some of the key players operating in the ursodeoxycholic acid market are ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhangshanbelling, Dipharma Francis, Grindeks, Erregierre, Abil Chempharma, Biotavia Labs, Suzhou Tianlu, Arcelor Chemicals.
The ursodeoxycholic acid market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ursodeoxycholic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ursodeoxycholic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ursodeoxycholic Acid Market - Supply Chain
4.5. Global Ursodeoxycholic Acid Market Forecast
4.5.1. Ursodeoxycholic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ursodeoxycholic Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ursodeoxycholic Acid Market Absolute $ Opportunity
5. Global Ursodeoxycholic Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ursodeoxycholic Acid Market Size and Volume Forecast by Type
5.3.1. Synthetic UDCA
5.3.2. Extraction UDCA
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ursodeoxycholic Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ursodeoxycholic Acid Market Size and Volume Forecast by Application
6.3.1. Pharmacy
6.3.2. Health Products
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ursodeoxycholic Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ursodeoxycholic Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ursodeoxycholic Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ursodeoxycholic Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ursodeoxycholic Acid Demand Share Forecast, 2019-2026
9. North America Ursodeoxycholic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ursodeoxycholic Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ursodeoxycholic Acid Market Size and Volume Forecast by Application
9.4.1. Pharmacy
9.4.2. Health Products
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ursodeoxycholic Acid Market Size and Volume Forecast by Type
9.7.1. Synthetic UDCA
9.7.2. Extraction UDCA
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ursodeoxycholic Acid Demand Share Forecast, 2019-2026
10. Latin America Ursodeoxycholic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ursodeoxycholic Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ursodeoxycholic Acid Market Size and Volume Forecast by Application
10.4.1. Pharmacy
10.4.2. Health Products
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ursodeoxycholic Acid Market Size and Volume Forecast by Type
10.7.1. Synthetic UDCA
10.7.2. Extraction UDCA
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ursodeoxycholic Acid Demand Share Forecast, 2019-2026
11. Europe Ursodeoxycholic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ursodeoxycholic Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ursodeoxycholic Acid Market Size and Volume Forecast by Application
11.4.1. Pharmacy
11.4.2. Health Products
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ursodeoxycholic Acid Market Size and Volume Forecast by Type
11.7.1. Synthetic UDCA
11.7.2. Extraction UDCA
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential nalysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ursodeoxycholic Acid Demand Share, 2019-2026
12. Asia Pacific Ursodeoxycholic Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ursodeoxycholic Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ursodeoxycholic Acid Market Size and Volume Forecast by Application
12.4.1. Pharmacy
12.4.2. Health Products
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ursodeoxycholic Acid Market Size and Volume Forecast by Type
12.7.1. Synthetic UDCA
12.7.2. Extraction UDCA
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ursodeoxycholic Acid Demand Share, 2019-2026
13. Middle East & Africa Ursodeoxycholic Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ursodeoxycholic Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ursodeoxycholic Acid Market Size and Volume Forecast by Application
13.4.1. Pharmacy
13.4.2. Health Products
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ursodeoxycholic Acid Market Size and Volume Forecast by Type
13.7.1. Synthetic UDCA
13.7.2. Extraction UDCA
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ursodeoxycholic Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ursodeoxycholic Acid Market: Market Share Analysis
14.2. Ursodeoxycholic Acid Distributors and Customers
14.3. Ursodeoxycholic Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ICE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Mitsubishi Tanabe Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daewoong Chemical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PharmaZell GmbH
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Zhangshanbelling
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dipharma Francis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Grindeks
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Erregierre
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abil Chempharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biotavia Labs
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Suzhou Tianlu
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Arcelor Chemicals
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
